Fundraising Fox

Eiger Biopharmaceuticals

Santa Clara, US · Delaware corporation · 2 known investors

Biotech

Founders & leadership

NK
Nina KjellsonDirector
EE
Ed EnglemanDirector
JG
Jeffrey GlennDirector
DC
David CoryExecutive Officer, Director

Investors · 2

Canaan PartnersreportedStamford · $500K – $20Mvia Nina Kjellson · board
Vivo CapitalreportedPalo Alto · $10M – $50Mvia Edgar G. Engleman · board

Reported raises · per SEC filings

Form D private placements
▶$6MraisedNov 2015 · 4 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Thomas DietzDirector
  • David CoryExecutive Officer, Director
  • Nina KjellsonDirector
  • Ed EnglemanDirector
  • Jeffrey GlennDirector
Offering amount
$6M
Amount sold
$6M
First sale
Nov 2015
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$14.5MraisedMar 2015 · 8 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Nina KjellsonDirector
  • Ed EnglemanDirector
  • Jeffrey GlennDirector
  • David CoryExecutive Officer, Director
Offering amount
$14.6M
Amount sold
$14.5M
First sale
Apr 2011
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.